- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Appetite Hormone Weakens Bones
28 January 2000 7:00 pm
The fat-busting hormone leptin curbs the appetite and sends preteens lurching into puberty. Now comes news of a more surprising connection: osteoporosis. Researchers report in the current issue of Cell that mice lacking leptin grow stronger and thicker bones than normal. The finding could eventually lead to new therapies for osteoporosis, which plagues about 28 million Americans, mostly women.
The three best known risk factors for osteoporosis are menopause, intense athleticism, and anorexia. The bone loss seems to be spurred by a hormone imbalance: either a lack of sex steroids, or too many stress or appetite-control hormones. Mice that are bred to be leptin deficient should also be prone to bone loss, based on their similarity to human risk factors--they're sterile, stressed out, and eat as if they are starving. So geneticist Gerard Karsenty of Baylor College of Medicine in Houston, Texas, had a hunch that low leptin levels in the mutant mice would weaken bones as in osteoporosis.
But when Karsenty and his colleagues examined the bones of mice that lacked leptin or its receptor, they found that the mutant animals had up to three times the bone volume and strength of their normal counterparts. "I was flabbergasted," recalls Karsenty. By tracking bone formation with radioisotopes, the researchers traced the bone buildup to overtime work of cells called osteoblasts. Further, leptin infusions into the rodents' brains whittled away the excess bone. But leptin did not appear to be acting directly on the osteoblasts--rather, leptin appears to act on its receptor in the hypothalamus and then relay some secondary signal to the body.
"It is a very strange, unpredicted result and very intriguing," says leptin researcher Joel Elmquist of Beth Israel Deaconess Medical Center in Boston, who is stymied as to the nature of the secondary signal coming from the hypothalamus. Although leptin inhibits bone growth, there may be another compound in the brain that can stimulate the osteoblasts. Karsenty is now searching for such a stimulator, which could be the beginning of a cure for osteoporosis.